Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03014427

Development of a Biological Database in the Field of Operative Intensive Care

The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Uniklinik RWTH Aachen

Aachen, 52074, Germany

Location status: Recruiting

Location contact

Christian Stoppe, PD Dr. med.

CONTACT

[email protected]

About this study

The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary.

Sample volumes are defined as follows:

  • Peripheral blood: up to a total of 150 ml distributed to a maximum of 10 morning blood samples (approximately 15 ml blood per blood sample) during the inpatient stay in the intensive care unit (fixed times are admission and discharge of the intensive care unit)
  • Urine: a total of up to 200 ml of catheter urine distributed to a maximum of 10 morning withdrawals during inpatient stays in the intensive care unit (defined times are admission and discharge from the intensive care unit)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients after admission to the intensive care unit
  • 18 years or older
  • signed informed consent

Exclusion criteria

  • No exclusion criteria are formulated with regard to the objective of the register to record intensive care patients in general. Patients with multiple comorbidities, organ dysfunctions, and non-compliance for a curatively-intended therapy should also be recorded in the register. A palliative treatment or decision for best supportive care is not an exclusion criterion for registering.

Treatment and study plan

Biological Database

Other

Biological Database

Primary outcomes

  1. Interleukin 6 value [nmol/l]

    Time frame: 10 days

    Record of clinically relevant parameters

  2. Interleukin 10 [nmol/l]

    Time frame: 10 days

    Record of clinically relevant parameters

  3. Adrenomedullin value [nmol/l]

    Time frame: 10 days

    Record of clinically relevant parameters

  4. Tumornekrosefaktor alpha [nmol/l]

    Time frame: 10 days

    Record of clinically relevant parameters

  5. Procalcitonin [nmol/l]

    Time frame: 10 days

    Record of clinically relevant parameters

Study contacts

Contact information is provided by the study sponsor or research team.

Christian Stoppe, Dr. med.

CONTACT

[email protected]

0241 80 36575

Christina Kalvelage, M. Sc.

CONTACT

[email protected]

0241 80 36485

Sponsors and collaborators

Lead sponsor

RWTH Aachen University

Other

Registry information

Official study title

Development of a Biological Database in the Field of Operative Intensive Care for the Recording of Clinically Relevant Parameters of Critically Ill Intensive Patients

Acronym: Biobank OIM

Important dates

Study start
2017
Primary completion
2050
Study completion
2050
First posted
Jan 9, 2017
Registry last updated
Sep 18, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.